SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-20-009847
Filing Date
2020-04-27
Accepted
2020-04-27 17:19:27
Documents
5
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A formdefa.htm DEFA14A 51373
2 graphic01.jpg GRAPHIC 89318
3 graphic02.jpg GRAPHIC 124054
4 graphic03.jpg GRAPHIC 41516
5 graphic04.jpg GRAPHIC 9485
  Complete submission text file 0001140361-20-009847.txt   416965
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32302 | Film No.: 20821222
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences